NEWS
Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 3rd Annual mRNA Process Development & Manufacturing Summit
Applied DNA Sciences (NASDAQ:APDN) announced its participation in the 3rd Annual mRNA Process Development & Manufacturing Summit in Boston from September 17-19, 2024. The company will showcase its Linea™ IVT platform, a solution for faster and better mRNA production with reduced double-stranded RNA contamination.
LineaRx, a majority-owned Applied DNA company, will present the platform, which combines an enzymatically produced DNA template with a next-generation RNA polymerase. Additionally, LineaRx and mRNA CDMO partner Kudo Biotechnology will co-host a seminar luncheon on September 19 to present data demonstrating Linea IVT's capability for rapid manufacturing of dsRNA-mitigated mRNA.
LineaRx, a majority-owned Applied DNA company, will present the platform, which combines an enzymatically produced DNA template with a next-generation RNA polymerase. Additionally, LineaRx and mRNA CDMO partner Kudo Biotechnology will co-host a seminar luncheon on September 19 to present data demonstrating Linea IVT's capability for rapid manufacturing of dsRNA-mitigated mRNA.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
1968Followers
101Following
17KVisitors
Follow